These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6883362)

  • 1. Phase II study of vindesine infusion in visceral metastatic malignant melanoma.
    Wagstaff J; Anderson HA; Shiu W; Thatcher N
    Cancer Treat Rep; 1983 Sep; 67(9):839-40. PubMed ID: 6883362
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
    Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
    Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
    [No Abstract]   [Full Text] [Related]  

  • 3. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of vindesine in metastatic malignant melanoma.
    Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
    Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of vindesine in patients with malignant melanoma.
    Camacho FJ; Young CW; Wittes RE
    Cancer Treat Rep; 1980 Jan; 64(1):179-81. PubMed ID: 7379054
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized study of continuous infusion vindesine versus vinblastine in adults with refractory metastatic sarcomas.
    Yap BS; Benjamin RS; Plager C; Burgess MA; Papadoupoulos N; Bodey GP
    Am J Clin Oncol; 1983 Apr; 6(2):235-8. PubMed ID: 6829497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pilot study with vindesine as monotherapy in metastatic malignant melanomas].
    Balda BR; Jehn U; Klövekorn W; Wohlrab A
    MMW Munch Med Wochenschr; 1983 Jan; 125(3):54-6. PubMed ID: 6402675
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma.
    Retsas S; Thomas C; Hobbs JR
    Clin Oncol; 1981 Mar; 7(1):33-7. PubMed ID: 7214761
    [No Abstract]   [Full Text] [Related]  

  • 11. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
    Quagliana JM; Stephens RL; Baker LH; Costanzi JJ
    J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion.
    Yap HY; Blumenschein GR; Bodey GP; Hortobagyi GN; Buzdar AU; DiStefano A
    Cancer Treat Rep; 1981; 65(9-10):775-9. PubMed ID: 7273012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors.
    Smith IE; Hedley DW; Powles TJ; McElwain TJ
    Cancer Treat Rep; 1978 Oct; 62(10):1427-33. PubMed ID: 709548
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with the colony-forming (stem cell) assay of in vitro chemosensitivity in the management of patients with advanced malignant melanoma.
    MacKie RM; Gaukroger JM; Wilson L; Gold J
    Cancer Treat Rep; 1984 Sep; 68(9):1185-8. PubMed ID: 6478453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of vindesine in patients with metastatic breast cancer.
    Cobleigh MA; Williams SD; Einhorn LH
    Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II evaluation of vindesine in the treatment of malignant glioma.
    Alavi JB; Weiler CB; Bruno LA
    Cancer Treat Rep; 1984 May; 68(5):807-8. PubMed ID: 6722835
    [No Abstract]   [Full Text] [Related]  

  • 18. A multicentre phase II trial of vindesine in malignant melanoma.
    Carmichael J; Atkinson RJ; Calman KC; Mackie RM; Naysmith AM; Smyth JF
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1293-5. PubMed ID: 6891927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of IV vinflunine in patients with chemotherapy naive metastatic malignant melanoma.
    Olver IN; Byrne MJ; Walpole E; Vorobiof D; Jacobs C; Maart K; Hewitt S; McAdam G; Pouget JC; Pinel MC
    Eur J Cancer; 2007 Aug; 43(12):1829-32. PubMed ID: 17631996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Mar; 66(3):567-9. PubMed ID: 6174231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.